|
|
Life Science
|
|
Medical Information Technology
|
|
The life sciences industry as a whole is evolving towards newer and faster technological advancement in information technologies. Biotechnology and pharmaceutical companies need access to key scientific data to make informed decisions, and at specific times during the clinical trial process. Regulatory agencies are requiring electronic submissions.
Moving, querying, and storing information,
including images and textual information, throughout the continuum of care is critical to the success of patient outcomes and improved efficiencies in the care of patients.
Recent drug safety issues and consumer awareness have demonstrated the importance of electronic data capture and advanced clinical trial software solutions. These technologies allow companies to effectively monitor and progress through critical stages of drug development, and successfully address potential safety concerns.
Practice Leaders:
John Baker - Boston
Sue Rossiter - St. Albans
Consultants:
Alice Benson - Boston
Paul Bulteel - London
Michael Burroughs - St. Louis
Kay Chen - Shanghai
Clare Cizek - Minneapolis
Diane Coletti - Boston
John Cornille - New York
Eric Dieny - Shanghai
Supriya Dikshit - Mumbai
Caroline Edwards - Hong Kong**
Jeffrey Golove - New York
John R. Hamilton - Pittsburgh
Sophie Harle - Singapore
Rives Hewitt - Toronto
Sussannah Kelly - Toronto
Donald Kilinski - New York
Victor Kleinman - Palm Beach
Helen Kwok - Shanghai
Victoria Lim - Singapore
Kelvin Ling - Hong Kong**
James Martin - Washington, DC
Tara McKernan - Stamford
John McLean - Chicago***
Mike Nagata - Tokyo
Mercedes Paz - Los Angeles
Kimberley Rice - Princeton
Ruth Stone - St. Albans
Johannes Suciu - Frankfurt
Naomi Tachibana - Tokyo
Phoebe Wan - Hong Kong**
Jeffrey Webb - St. Albans
Jan Westerink - Amsterdam**
Lance Winn - Austin
Shawn Woessner - Minneapolis
Debra Young - Denver
|
|